Structure and function of complement C5 convertase enzymes
MK Pangburn, N Rawal - Biochemical Society Transactions, 2002 - portlandpress.com
The multisubunit enzymes of the complement system that cleave C5 have many unusual
properties, the most striking of which is that they acquire their specificity for C5 following …
properties, the most striking of which is that they acquire their specificity for C5 following …
Structural basis for therapeutic inhibition of complement C5
Activation of complement C5 generates the potent anaphylatoxin C5a and leads to pathogen
lysis, inflammation and cell damage. The therapeutic potential of C5 inhibition has been …
lysis, inflammation and cell damage. The therapeutic potential of C5 inhibition has been …
Structure, function and control of complement C5 and its proteolytic fragments
N S. Laursen, F Magnani… - Current molecular …, 2012 - benthamdirect.com
… Functional role of the noncatalytic subunit of complement C5 convertase. J Immunol 2000; …
The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA…
The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA…
A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration
D Mastellos, JC Papadimitriou, S Franchini… - The Journal of …, 2001 - journals.aai.org
Components of innate immunity have recently been implicated in the regulation of
developmental processes. Most strikingly, complement factors appear to be involved in limb …
developmental processes. Most strikingly, complement factors appear to be involved in limb …
Complement C5 protein as a marker of subclinical atherosclerosis
D Martínez-López, R Roldan-Montero… - Journal of the American …, 2020 - jacc.org
… Plasma levels of complement C5 were analyzed in relation to the presence of generalized
(>2 plaques) or incipient (0 to 2 plaques) subclinical atherosclerosis in 2 independent clinical …
(>2 plaques) or incipient (0 to 2 plaques) subclinical atherosclerosis in 2 independent clinical …
Complement C5 mediates experimental tubulointerstitial fibrosis
Renal fibrosis is the final common pathway of most progressive renal diseases. C5 was
recently identified as a risk factor for liver fibrosis. This study investigated the role of C5 in the …
recently identified as a risk factor for liver fibrosis. This study investigated the role of C5 in the …
Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
PR Craddock, D Hammerschmidt, JG White… - The Journal of clinical …, 1977 - jci.org
Activated plasma complement will induce biphasic aggregation of human granulocytes
dectable by standard nephelometric techniques. The responsible active component was …
dectable by standard nephelometric techniques. The responsible active component was …
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
Respiratory failure and acute kidney injury (AKI) are associated with high mortality in SARS-CoV-2-associated
Coronavirus disease 2019 (COVID-19). These manifestations are linked …
Coronavirus disease 2019 (COVID-19). These manifestations are linked …
Primary complement C5 deficiencies–molecular characterization and clinical review of two families
L Schejbel, D Fadnes, H Permin, KT Lappegård… - Immunobiology, 2013 - Elsevier
… All activation pathways lead to generation of a C3 convertase, and subsequently to formation
of a complement C5 convertase which cleaves C5 into C5a (residues 678–751) and C5b. …
of a complement C5 convertase which cleaves C5 into C5a (residues 678–751) and C5b. …
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria
A Röth, J Nishimura, Z Nagy… - Blood, The Journal …, 2020 - ashpublications.org
Complement C5 inhibition is the standard of care (SoC) for patients with paroxysmal
nocturnal hemoglobinuria (PNH) with significant clinical symptoms. Constant and complete …
nocturnal hemoglobinuria (PNH) with significant clinical symptoms. Constant and complete …